Delivery Order SPE2DB22D2206-SPE2DB25FHY70
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of ISONIAZID 300 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,342.70. The contract is a Firm Fixed Price Delivery Order with a period of performance through June 24, 2025. There is no set-aside designation mentioned for this award. Amerisourcebergen...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,707.64 firm fixed-price delivery order is for the supply of ISONIAZID 100 MG TABLET 100S, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of ISONIAZID 300 MG TABLET 100S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,651.23 and an ultimate completion date of May 28, 2025. The contract is not set aside and was awarded on May 27, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in SAM.gov and serves as a critical supplier of...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract is a delivery order for the medication ISONIAZID 300 MG TABLET 100S, with a ceiling value of $5,070.79 and a period of performance through July 14, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,248.27, is for the delivery of ISONIAZID 300 MG TABLET 100S, a medication. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about major subcontractors. This delivery...
- This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF7XJ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,053.49 firm fixed-price delivery order is for the supply of ISONIAZID 300 MG TABLET 30S, a pharmaceutical product, with a period of performance through March 18, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Isoniazid 300 mg tablets, a medication used to treat tuberculosis. The contract has a ceiling value of $2,035.42 and a period of performance through March 3, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ISONIAZID 100 MG TABLET 100S, a medical product, with a ceiling value of $8,453.92. The contract is a firm fixed price delivery order, with a completion date of July 14, 2025. This contract is not set-aside and is awarded as part of Amerisourcebergen Drug Corp's larger Indefinite...
- This federal contract award, valued at $807,318.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for a firm fixed price with an ultimate completion date of January 16, 2025. The contract is not set aside and allows for the provision of a wide range of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain...
- This federal contract award is a $45,541.02 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and has an ultimate completion date of June 24, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHY70Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $3,470.84 for the delivery of ISONIAZID 300 MG TABLET 30S. It is a Firm Fixed Price contract with an ultimate completion date of July 18, 2025. Amerisourcebergen Drug Corp, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and running through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract does not have a set-aside designation, indicating it was competitively awarded.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 7/17/25 |